Characterization of Cancer Tissue Using 3D Biosynthetic Material
NCT ID: NCT02678078
Last Updated: 2016-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2016-02-29
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
NCT01365962
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
NCT05600933
Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer
NCT01344837
Microarray Analysis of Gene Expression in Liver Tumors
NCT00373737
"Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients"
NCT06759714
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Analyzing biopsy samples
Analyzing biopsy samples that is preformed as part of the patient treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rambam Health Care Campus
OTHER
Technion, Israel Institute of Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dror Seliktar
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dror seliktar, Prof
Role: STUDY_DIRECTOR
Technion, Israel Institute of Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rambam
Haifa, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Tarek Saadi, Dr.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0671-15-RMB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.